Price Bump From M&A Rumors Earns Acadia A Vetr Downgrade By: Benzinga via Benzinga February 15, 2017 at 17:03 PM EST The Vetr crowd downgraded their rating for ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) on Wednesday, from 4 stars (Buy), issued nine days ... Read More >> Related Stocks: Acadia Pharmaceutica Astrazeneca Plc ADR